Juan Graham - 08 Dec 2022 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Financial Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol
FGEN
Transactions as of
08 Dec 2022
Net transactions value
-$85,498
Form type
4
Filing time
15 Dec 2022, 16:23:04 UTC
Previous filing
08 Sep 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale $78,103 -5,263 -9.4% $14.84* 50,628 08 Dec 2022 Direct F1, F2
transaction FGEN Common Stock Sale $7,395 -478 -0.94% $15.47* 50,150 08 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 plan.
F2 These shares were sold in multiple transactions on the reported date with prices ranging from $14.38 to $15.355 resulting in a weighted average price of $14.84. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.